Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting

Journal of Cell Science

Volumn 122, Issue 8, 2009, Pages 1119-1125

  Sciorati, Clara ^a   Touvier, Thierry ^a   Buono, Roberta ^a   Pessina, Patrizia ^b   François, Stephanie ^b   Perrotta, Cristiana ^a   Meneveri, Raffaella ^b   Clementi, Emilio ^c,d   Brunelli, Silvia ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Cachexia; Muscle regeneration; Necdin; TNF

Indexed keywords

CASPASE 3; CASPASE 9; MESSENGER RNA; NECDIN; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; CASP3 PROTEIN, MOUSE; CASP9 PROTEIN, MOUSE; NERVE PROTEIN; NUCLEAR PROTEIN; TNFRSF1A PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; COLON CARCINOMA; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION REGULATION; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE MASS; MUSCLE REGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; COLON TUMOR; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; REGENERATION; TIME; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS;

ADENOCARCINOMA; ANIMALS; CACHEXIA; CASPASE 3; CASPASE 9; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REGENERATION; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 66849141985     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.041665     Document Type: Article

References (31)

1. Acharyya, S., Ladner, K., Nelsen, L., Damrauer, J., Reiser, P., Swoap, S. and Guttridge, D. (2004). Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 114, 370-378.
2. Alter, J., Rozentzweig, D. and Bengal, E. (2008). Inhibition of myoblast differentiation by TNFalpha is mediated by c-Jun N-terminal kinase 1 and Leukemia inhibitory factor. J. Biol. Chem. 283, 23224-23234.
3. Argiles, J. M., Busquets, S. and Lopez-Soriano, F. J. (2006). Cytokines as mediators and targets for cancer cachexia. Cancer Treat. Res. 130, 199-217.
4. Barreiro, E., de la Puente, B., Busquets, S., Lopez-Soriano, F. J., Gea, J. and Argiles, J. M. (2005). Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats. FEBS Lett. 579, 1646-1652.
5. Bronfman, F. C., Tcherpakov, M., Jovin, T. M. and Fainzilber, M. (2003). Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J. Neurosci. 23, 3209-3220.
6. Brunelli, S., Tagliafico, E., De Angelis, F. G., Tonlorenzi, R., Baesso, S., Ferrari, S., Niinobe, M., Yoshikawa, K., Schwartz, R. J., Bozzoni, I. et al. (2004). Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells. Circ. Res. 94, 1571-1578.
7. Charge, S. B. and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
8. Chung, L. and Ng, Y. C. (2006). Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscle. Biochim. Biophys. Acta 1762, 103-109.
9. Coletti, D., Yang, E., Marazzi, G. and Sassoon, D. (2002). TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways. EMBO J. 21, 631-642.
10. Coletti, D., Moresi, V., Adamo, S., Molinaro, M. and Sassoon, D. (2005). Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43, 120-128.
11. Deponti, D., François, S., Baesso, S., Sciorati, C., Innocenzi, A., Broccoli, V., Muscatelli, F., Meneveri, R, Clementi, E., Cossu, G. et al. (2007). Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. J. Cell Biol. 179, 305-319.
12. Kuwako, K., Hosokawa, A., Nishimura, I., Uetsuki, T., Yamada, M., Nada, S., Okada, M. and Yoshikawa, K. (2005). Disruption of the paternal necdin gene diminishes TrkA signaling for sensory neuron survival. J. Neurosci. 25, 7090-7099.
13. Langen, R. C., Van Der Velden, J. L., Schols, A. M., Kelders, M. C., Wouters, E. F. and Janssen-Heininger, Y. M. (2004). Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 18, 227-237.
14. Li, Y. P., Chen, Y., Li, A. S. and Reid, M. B. (2003). Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am. J. Physiol. Cell Physiol. 285, C806-C812.
15. Moresi, V., Pristera, A., Scicchitano, B. M., Molinaro, M., Teodori, L., Sassoon, D., Adamo, S. and Coletti, D. (2008). Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response. Stem Cells 26, 997-1008.
16. Morley, J. E., Thomas, D. R. and Wilson, M. M. (2006). Cachexia: pathophysiology and clinical relevance. Am. J. Clin. Nutr. 83, 735-743.
17. Musaro, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E. R., Sweeney, H. L. and Rosenthal, N. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195-200.
18. Muscaritoli, M., Bossola, M., Aversa, Z., Bellantone, R. and Rossi Fanelli, F. (2006). Prevention and treatment of cancer cachexia: new insights into an old problem. Eur. J. Cancer. 42, 31-41.
19. Muscatelli, F., Abrous, D. N., Massacrier, A., Boccaccio, I., Le Moal, M., Cau, P. and Cremer, H. (2000). Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum. Mol. Genet. 9, 3101-3110.
20. Neznanov, N., Kondratova, A., Chumakov, K. M., Angres, B., Zhumabayeva, B., Agol, V. I. and Gudkov, A. V. (2001). Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J. Virol. 75, 10409-10420.
21. Paland, N., Bohme, L., Gurumurthy, R. K., Maurer, A., Szczepek, A. J. and Rudel, T. (2008). Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis. J. Biol. Chem. 283, 6438-6448.
22. Schwarzkopf, M., Coletti, D., Sassoon, D. and Marazzi, G. (2006). Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev. 20, 3440-3452.
23. Siu, P. M., Pistilli, E. E., Murlasits, Z. and Alway, S. E. (2006). Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 proteins in young adult and aged rats. J. Appl. Physiol. 100, 907-916.
24. Song, Y. H., Li, Y., Du, J., Mitch, W. E., Rosenthal, N. and Delafontaine, P. (2005). Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 115, 451-458.
25. Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D. and Glass, D. J. (2004). The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395-403.
26. Tanaka, Y., Eda, H., Tanaka, T., Udagawa, T., Ishikawa, T., Horii, I., Ishitsuka, H., Kataoka, T. and Taguchi, T. (1990). Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 50, 2290-2295.
27. Tisdale, M. J. (2002). Cachexia in cancer patients. Nat. Rev. Cancer 2, 862-871.
28. Tisdale, M. J. (2005). Molecular pathways leading to cancer cachexia. Physiology 20, 340-348.
29. Tisdale, M. J. (2006). Clinical anticachexia treatments. Nutr. Clin. Pract. 21, 168-174.
30. Yazidi-Belkoura, I. E., Adriaenssens, E., Dolle, L., Descamps, S. and Hondermarck, H. (2003). Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated antiapoptotic activity of nerve growth factor in breast cancer cells. J. Biol. Chem. 278, 16952.
31. Zhou, W., Jiang, Z., Tian, J., Jiang, J., Li, N. and Li, J. (2003). Role of NF-kappaB and cytokine in experimental cancer cachexia. World J. Gastroenterol. 9, 1567-1570.